SARS-CoV-2 疫苗：成就斐然，仍有许多需要学习。
SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.
机构信息
the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (M.C., H.C.L., A.S.F.).
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (B.S.G.).
出版信息
Ann Intern Med. 2021 May;174(5):687-690. doi: 10.7326/M21-0111. Epub 2021 Jan 19.
Abstract
As COVID vaccines roll out, internists and other health care providers are being turned to as trusted sources of information for patients and communities. Here, experts from NIAID outline the current state of knowledge regarding such vaccines. They contrast vaccine platforms, summarize clinical trial data regarding efficacy and safety, and comment on key questions including the ability of current vaccines to protect against infection and to decrease the prevalence of virus in the community.
摘要
随着 COVID 疫苗的推出，内科医生和其他医疗保健提供者正成为患者和社区信任的信息来源。在这里，NIAID 的专家概述了当前关于此类疫苗的知识状况。他们对比了疫苗平台，总结了关于疗效和安全性的临床试验数据，并就当前疫苗预防感染和减少社区病毒流行的能力等关键问题发表了评论。
相似文献
1
SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.SARS-CoV-2 疫苗：成就斐然，仍有许多需要学习。
Ann Intern Med. 2021 May;174(5):687-690. doi: 10.7326/M21-0111. Epub 2021 Jan 19.
2
COVID-19 Vaccine: Practical Clinical Considerations.新型冠状病毒肺炎疫苗：实用临床注意事项。
Ann Intern Med. 2021 May;174(5):694. doi: 10.7326/M21-1260. Epub 2021 Mar 26.
3
Keeping track of the SARS-CoV-2 vaccine pipeline. 跟踪 SARS-CoV-2 疫苗研发管线。
Nat Rev Immunol. 2020 Nov;20(11):650. doi: 10.1038/s41577-020-00455-1.
4
All eyes on a hurdle race for a SARS-CoV-2 vaccine.所有人的目光都聚焦在新冠病毒疫苗的一场障碍赛上。
Nature. 2020 Oct;586(7830):501-502. doi: 10.1038/d41586-020-02926-w.
5
Could mixing COVID vaccines boost immune response?混合接种新冠疫苗能增强免疫反应吗？
Nature. 2021 Feb;590(7846):375-376. doi: 10.1038/d41586-021-00315-5.
6
The COVID-19 vaccine development landscape.2019冠状病毒病疫苗的研发情况。
Nat Rev Drug Discov. 2020 May;19(5):305-306. doi: 10.1038/d41573-020-00073-5.
7
Anticipating Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Testing, Licensure, and Recommendations for Use.预测严重急性呼吸综合征冠状病毒2疫苗的测试、许可及使用建议。
J Pediatr. 2020 Sep;224:124-128. doi: 10.1016/j.jpeds.2020.06.048. Epub 2020 Jun 19.
8
Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.开发安全有效的新冠疫苗——“极速行动”计划的策略与方法。
N Engl J Med. 2020 Oct 29;383(18):1701-1703. doi: 10.1056/NEJMp2027405. Epub 2020 Aug 26.
9
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.用于开发 SARS-CoV-2 候选疫苗的新型疫苗生产平台。
Vaccine. 2021 Jan 8;39(2):197-201. doi: 10.1016/j.vaccine.2020.11.054. Epub 2020 Nov 24.
10
Developing Covid-19 Vaccines at Pandemic Speed.以大流行速度研发新冠疫苗。
N Engl J Med. 2020 May 21;382(21):1969-1973. doi: 10.1056/NEJMp2005630. Epub 2020 Mar 30.
引用本文的文献
1
Vaccination for solid organ transplanted patients: Recommendations, efficacy, and safety.实体器官移植患者的疫苗接种：建议、疗效与安全性
World J Transplant. 2024 Dec 18;14(4):92172. doi: 10.5500/wjt.v14.i4.92172.
2
Impact and Effectiveness of COVID-19 Vaccines Based on Machine Learning Analysis of a Time Series: A Population-Based Study.基于时间序列机器学习分析的新冠疫苗影响与效果：一项基于人群的研究
J Clin Med. 2024 Oct 2;13(19):5890. doi: 10.3390/jcm13195890.
3
The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model.腺病毒载体疫苗接种途径在 SARS-CoV-2/K18-hACE2 小鼠感染模型中的保护、病毒控制和传播中的作用。
Front Immunol. 2023 Aug 16;14:1188392. doi: 10.3389/fimmu.2023.1188392. eCollection 2023.
4
The Therapeutic Potential of Natural Dietary Flavonoids against SARS-CoV-2 Infection.天然膳食类黄酮对抗 SARS-CoV-2 感染的治疗潜力。
Nutrients. 2023 Aug 3;15(15):3443. doi: 10.3390/nu15153443.
5
Virus-Subtype-Specific Cellular and Humoral Immune Response to a COVID-19 mRNA Vaccine in Chronic Kidney Disease Patients and Renal Transplant Recipients.慢性肾脏病患者和肾移植受者对新冠病毒mRNA疫苗的病毒亚型特异性细胞免疫和体液免疫反应
Microorganisms. 2023 Jul 5;11(7):1756. doi: 10.3390/microorganisms11071756.
6
Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.在一项随机对照临床试验中，通过电穿孔增强表达 HIV 亚型 C Env 的重组水疱性口炎病毒对 HIV DNA 进行初免，观察到细胞和体液对 HIV 的应答。
Vaccine. 2023 Apr 17;41(16):2696-2706. doi: 10.1016/j.vaccine.2023.03.015. Epub 2023 Mar 17.
7
Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech.辉瑞-生物科技 COVID-19 疫苗接种后的抗中性粒细胞胞浆抗体相关性血管炎。
Intern Med. 2022;61(19):2925-2929. doi: 10.2169/internalmedicine.9807-22. Epub 2022 Oct 1.
8
A microarray patch SARS-CoV-2 vaccine induces sustained antibody responses and polyfunctional cellular immunity.一种微阵列贴片式新冠病毒疫苗可诱导持续的抗体反应和多功能细胞免疫。
iScience. 2022 Oct 21;25(10):105045. doi: 10.1016/j.isci.2022.105045. Epub 2022 Aug 30.
9
Repurposing antiviral phytochemicals from the leaf extracts of Spondias mombin (Linn) towards the identification of potential SARSCOV-2 inhibitors.从三叶榕（Linn）叶提取物中重新利用抗病毒植物化学物质，以鉴定潜在的 SARSCOV-2 抑制剂。
Sci Rep. 2022 Jun 28;12(1):10896. doi: 10.1038/s41598-022-14558-3.
10
Political orientation, moral foundations, and COVID-19 social distancing.政治倾向、道德基础与新冠疫情社交隔离
PLoS One. 2022 Jun 24;17(6):e0267136. doi: 10.1371/journal.pone.0267136. eCollection 2022.
Zotero 插件